NasdaqGS - Nasdaq Real Time Price USD
HilleVax, Inc. (HLVX)
1.9000
-0.0100
(-0.52%)
At close: May 9 at 4:00:00 PM EDT
1.9000
0.00
(0.00%)
After hours: May 9 at 4:02:07 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BORKOWSKI ASTRID Officer | Sale | Feb 8, 2024 | 214,892 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 4, 2024 | -- |
| FRAZIER LIFE SCIENCES X, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 4, 2024 | -- |
| HERSHBERG ROBERT M Chief Executive Officer | Sale | Feb 11, 2025 | 1,101,500 |
| KOHLI ADITYA PH.D. Director | Sale | May 22, 2024 | 764,878 |
| MALTBIE SHANE Chief Financial Officer | Sale | Feb 11, 2025 | 79,887 |
| MCLOUGHLIN SEAN Chief Operating Officer | Purchase | Mar 28, 2024 | 1,250 |
Related Tickers
EPIX ESSA Pharma Inc.
1.7200
+0.58%
ANTX AN2 Therapeutics, Inc.
1.2000
-1.64%
KZR Kezar Life Sciences, Inc.
4.2200
+2.43%
IKNA Ikena Oncology, Inc.
1.1300
+4.63%
GLTO Galecto, Inc.
2.7450
-1.96%
TBPH Theravance Biopharma, Inc.
8.98
-9.29%
SPRO Spero Therapeutics, Inc.
0.6200
+7.83%
IPSC Century Therapeutics, Inc.
0.5370
+3.27%
RPTX Repare Therapeutics Inc.
1.3600
0.00%
PMVP PMV Pharmaceuticals, Inc.
0.8827
-0.12%